METHOTREXATE, MITOXANTRONE, 5-FLUOROURACIL AND LEUCOVORIN IN METASTATIC BREAST-CANCER PATIENTS

被引：0
|
作者：
MERLINI, L
SECONDO, V
MAMMOLITI, S
BELLOTTI, P
CASTELLO, C
GALLO, L
机构：
来源：
ANTICANCER RESEARCH | 1994年 / 14卷 / 3B期
关键词：
BIOCHEMICAL MODULATION; SALVAGE TREATMENT; BREAST CANCER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We have evaluated the efficacy and toxicity of a chemotherapy consisting of methotrexate, mitoxantrone, 5-Fluorouracil and leucovorin in 21 advanced breast cancer patients. Among 20 evaluable patients, objective response was obtained in 6 patients (30%) with two complete responses, stable disease in 4 patients (20%), while 10 patients (50%) progressed. Median progression-free survival and survival were 10 and 15 months, respectively. The most frequently observed side-effects were myelosuppression and emesis; one patient, who had previously received doxorubicin at the maximum dose-limiting cardiac toxicity, died of congestive heart failure after the third cycle. This treatment is moderately effective for advanced breast cancer patients.
引用
收藏
页码：1423 / 1425
页数：3
相关论文
共 50 条
  • [1] Mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer
    Lemmens, J
    Berteloot, P
    Thomas, J
    Wildiers, J
    Paridaens, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (12) : 2114 - 2115
  • [2] THE IMPORTANCE OF DOSE SCHEDULING WITH MITOXANTRONE, 5-FLUOROURACIL AND LEUCOVORIN IN METASTATIC BREAST-CANCER
    JOLIVET, J
    BELANGER, K
    YELLE, L
    GUEVIN, R
    POTVIN, M
    WILSON, J
    RUDINSKAS, L
    LATREILLE, J
    DIONNE, J
    GAGNE, L
    AYOUB, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1994, 30A (05) : 626 - 628
  • [3] THERAPY OF PATIENTS WITH METASTATIC BREAST-CANCER WITH 5-FLUOROURACIL, LEUCOVORIN AND CARBOPLATIN
    PAI, LH
    SWAIN, SM
    VENZON, DJ
    REED, E
    POIRIER, MC
    GUPTABURT, S
    DENICOFF, AM
    ALLEGRA, CJ
    [J]. ANTI-CANCER DRUGS, 1992, 3 (05) : 463 - 469
  • [4] PHASE-II STUDY OF WEEKLY MITOXANTRONE, 5-FLUOROURACIL, AND LEUCOVORIN IN METASTATIC BREAST-CANCER
    REPETTO, L
    MIGLIETTA, L
    GARDIN, G
    LANFRANCO, C
    NASO, C
    MERLINI, L
    GIUDICI, S
    VENTURINO, A
    CAMPORA, E
    TESTORE, F
    ROSSO, R
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (02) : 133 - 137
  • [5] 5-FLUOROURACIL PLUS LEUCOVORIN IN WOMEN WITH METASTATIC BREAST-CANCER
    LOPRINZI, CL
    INGLE, JN
    SCHAID, DJ
    BUCKNER, JC
    EDMONSON, JH
    [J]. CLINICAL RESEARCH, 1989, 37 (02): : A469 - A469
  • [6] 5-FLUOROURACIL WITH LEUCOVORIN IN BREAST-CANCER
    LOPRINZI, CL
    [J]. CANCER, 1989, 63 (06) : 1045 - 1047
  • [7] COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, MITOXANTRONE AND 5-FLUOROURACIL IN PATIENTS WITH METASTATIC BREAST-CANCER
    YAP, HY
    ESPARZA, L
    BLUMENSCHEIN, GR
    HORTOBAGYI, GN
    BODEY, GP
    [J]. CANCER TREATMENT REVIEWS, 1983, 10 : 53 - 55
  • [8] MITOXANTRONE, 5-FLUOROURACIL AND LEVO-LEUCOVORIN AS SALVAGE TREATMENT IN ADVANCED BREAST-CANCER PATIENTS
    MAMMOLITI, S
    MERLINI, L
    CAROTI, C
    GALLO, L
    [J]. EUROPEAN JOURNAL OF CANCER, 1994, 30A (02) : 248 - 249
  • [9] Efficacy of mitoxantrone, 5-fluorouracil and high dose leucovorin combination in elderly patients with metastatic breast cancer
    Nascimben, O
    Biason, R
    D'Amanzo, P
    Gatti, C
    Oniga, F
    Medici, M
    Paccagnella, A
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 78 - 78
  • [10] MITOXANTRONE, CYCLOPHOSPHAMIDE, AND 5-FLUOROURACIL IN THE TREATMENT OF HORMONALLY UNRESPONSIVE METASTATIC BREAST-CANCER
    HOLMES, FA
    YAP, HY
    ESPARZA, L
    BUZDAR, AU
    HORTOBAGYI, GN
    BLUMENSCHEIN, GR
    [J]. SEMINARS IN ONCOLOGY, 1984, 11 (03) : 28 - 31
12345